MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasm

BackgroundAbrupt change in the caliber of the main pancreatic duct (MPD) with distal pancreatic atrophy (PA) was considered as one of worrisome features in the International Association of Pancreatology guideline and American College of Gastroenterology guideline for the management of intraductal pa...

Full description

Bibliographic Details
Main Authors: Tingting Lin, Xin Chen, Jingjing Liu, Yingying Cao, Wenjing Cui, Zhongqiu Wang, Cheng Wang, Xiao Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.894023/full
_version_ 1818231898861731840
author Tingting Lin
Xin Chen
Jingjing Liu
Yingying Cao
Wenjing Cui
Zhongqiu Wang
Cheng Wang
Xiao Chen
Xiao Chen
author_facet Tingting Lin
Xin Chen
Jingjing Liu
Yingying Cao
Wenjing Cui
Zhongqiu Wang
Cheng Wang
Xiao Chen
Xiao Chen
author_sort Tingting Lin
collection DOAJ
description BackgroundAbrupt change in the caliber of the main pancreatic duct (MPD) with distal pancreatic atrophy (PA) was considered as one of worrisome features in the International Association of Pancreatology guideline and American College of Gastroenterology guideline for the management of intraductal papillary mucinous neoplasms (IPMNs). However, this feature was not included in other guidelines. Moreover, the association between PA alone and malignancy in IPMNs has not been fully evaluated. In the present study, we investigated the role of image-based PA in identifying malignant IPMNs or invasive carcinoma.MethodsA total of 186 patients with IPMNs were included for analysis. The tumor size, location, MPD diameter, presence of a mural nodule (MN), and PA were evaluated using magnetic resonance imaging. Demographic information and serum carbohydrate antigen 19-9 and carcinoembryonic antigen (CEA) levels were also collected. IPMNs with high-grade dysplasia and associated invasive carcinoma were regarded as malignant IPMNs.ResultsPA was observed in 34 cases (18.3%). The occurrence of malignant IPMNs or invasive carcinoma in patients with PA were significantly higher than in those without PA (52.9% vs. 22.3%; 44.1% vs. 8.9%, all P < 0.01). Multivariate logistic regression analysis showed that PA was an independently associated factor for malignant IPMNs [odds ratio (OR) = 2.69, 95% confidence interval (CI): 1.07-6.78] or invasive carcinoma (OR = 7.78, 95%CI: 2.62-23.10) after modified with confounders. Subgroup analysis in MPD-involved IPMNs also indicated that PA was an independently associated factor for invasive carcinoma (OR = 9.72, 95%CI: 2.43-38.88). PA had a similar performance with MPD plus MN [the area under the curve (AUC) was both 0.71] in identifying malignancy. PA had a higher performance in identifying invasive carcinoma in MPD-involved IPMNs than MN (AUC = 0.71 vs. 0.65, P = 0.02).ConclusionOur data showed that imaging-based PA was associated with malignancy or invasive carcinoma regardless of abrupt change in the caliber of MPD in IPMNs. PA had an acceptable performance in identifying malignant IPMNs.
first_indexed 2024-12-12T10:57:43Z
format Article
id doaj.art-e693d31f5c4144c3b6b53e7f8340ce73
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-12T10:57:43Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-e693d31f5c4144c3b6b53e7f8340ce732022-12-22T00:26:37ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-06-011210.3389/fonc.2022.894023894023MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous NeoplasmTingting Lin0Xin Chen1Jingjing Liu2Yingying Cao3Wenjing Cui4Zhongqiu Wang5Cheng Wang6Xiao Chen7Xiao Chen8Department of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Radiology, Shanghai Sixth People’s Hospital, Shanghai, ChinaDepartment of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Radiology, Nanjing Drum Tower Hospital, Nanjing, ChinaDepartment of Radiology, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaInstitute of Radiation Medicine, Fudan University, Shanghai, ChinaBackgroundAbrupt change in the caliber of the main pancreatic duct (MPD) with distal pancreatic atrophy (PA) was considered as one of worrisome features in the International Association of Pancreatology guideline and American College of Gastroenterology guideline for the management of intraductal papillary mucinous neoplasms (IPMNs). However, this feature was not included in other guidelines. Moreover, the association between PA alone and malignancy in IPMNs has not been fully evaluated. In the present study, we investigated the role of image-based PA in identifying malignant IPMNs or invasive carcinoma.MethodsA total of 186 patients with IPMNs were included for analysis. The tumor size, location, MPD diameter, presence of a mural nodule (MN), and PA were evaluated using magnetic resonance imaging. Demographic information and serum carbohydrate antigen 19-9 and carcinoembryonic antigen (CEA) levels were also collected. IPMNs with high-grade dysplasia and associated invasive carcinoma were regarded as malignant IPMNs.ResultsPA was observed in 34 cases (18.3%). The occurrence of malignant IPMNs or invasive carcinoma in patients with PA were significantly higher than in those without PA (52.9% vs. 22.3%; 44.1% vs. 8.9%, all P < 0.01). Multivariate logistic regression analysis showed that PA was an independently associated factor for malignant IPMNs [odds ratio (OR) = 2.69, 95% confidence interval (CI): 1.07-6.78] or invasive carcinoma (OR = 7.78, 95%CI: 2.62-23.10) after modified with confounders. Subgroup analysis in MPD-involved IPMNs also indicated that PA was an independently associated factor for invasive carcinoma (OR = 9.72, 95%CI: 2.43-38.88). PA had a similar performance with MPD plus MN [the area under the curve (AUC) was both 0.71] in identifying malignancy. PA had a higher performance in identifying invasive carcinoma in MPD-involved IPMNs than MN (AUC = 0.71 vs. 0.65, P = 0.02).ConclusionOur data showed that imaging-based PA was associated with malignancy or invasive carcinoma regardless of abrupt change in the caliber of MPD in IPMNs. PA had an acceptable performance in identifying malignant IPMNs.https://www.frontiersin.org/articles/10.3389/fonc.2022.894023/fullpancreatic atrophyintraductal papillary mucinous neoplasmspancreasmalignancyinvasive carcinoma
spellingShingle Tingting Lin
Xin Chen
Jingjing Liu
Yingying Cao
Wenjing Cui
Zhongqiu Wang
Cheng Wang
Xiao Chen
Xiao Chen
MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasm
Frontiers in Oncology
pancreatic atrophy
intraductal papillary mucinous neoplasms
pancreas
malignancy
invasive carcinoma
title MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasm
title_full MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasm
title_fullStr MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasm
title_full_unstemmed MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasm
title_short MRI-Based Pancreatic Atrophy Is Associated With Malignancy or Invasive Carcinoma in Intraductal Papillary Mucinous Neoplasm
title_sort mri based pancreatic atrophy is associated with malignancy or invasive carcinoma in intraductal papillary mucinous neoplasm
topic pancreatic atrophy
intraductal papillary mucinous neoplasms
pancreas
malignancy
invasive carcinoma
url https://www.frontiersin.org/articles/10.3389/fonc.2022.894023/full
work_keys_str_mv AT tingtinglin mribasedpancreaticatrophyisassociatedwithmalignancyorinvasivecarcinomainintraductalpapillarymucinousneoplasm
AT xinchen mribasedpancreaticatrophyisassociatedwithmalignancyorinvasivecarcinomainintraductalpapillarymucinousneoplasm
AT jingjingliu mribasedpancreaticatrophyisassociatedwithmalignancyorinvasivecarcinomainintraductalpapillarymucinousneoplasm
AT yingyingcao mribasedpancreaticatrophyisassociatedwithmalignancyorinvasivecarcinomainintraductalpapillarymucinousneoplasm
AT wenjingcui mribasedpancreaticatrophyisassociatedwithmalignancyorinvasivecarcinomainintraductalpapillarymucinousneoplasm
AT zhongqiuwang mribasedpancreaticatrophyisassociatedwithmalignancyorinvasivecarcinomainintraductalpapillarymucinousneoplasm
AT chengwang mribasedpancreaticatrophyisassociatedwithmalignancyorinvasivecarcinomainintraductalpapillarymucinousneoplasm
AT xiaochen mribasedpancreaticatrophyisassociatedwithmalignancyorinvasivecarcinomainintraductalpapillarymucinousneoplasm
AT xiaochen mribasedpancreaticatrophyisassociatedwithmalignancyorinvasivecarcinomainintraductalpapillarymucinousneoplasm